肥大型心筋症に合併した心房細動に対する カテーテルアブレーション
Saved in:
Published in | 日大医学雑誌 Vol. 77; no. 4; pp. 255 - 260 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | Japanese |
Published |
日本大学医学会
01.08.2018
|
Subjects | |
Online Access | Get full text |
ISSN | 0029-0424 1884-0779 |
DOI | 10.4264/numa.77.4_255 |
Cover
Author | 戸坂, 俊雅 新井, 将 古川, 力丈 高橋, 啓子 黒川, 早矢香 若松, 雄二 中井, 俊子 永嶋, 孝一 大久保, 公恵 渡邉, 隆太 平山, 篤志 國本, 聡 奥村, 恭男 渡辺, 一郎 磯, 一貴 園田, 和正 |
---|---|
Author_xml | – sequence: 1 fullname: 磯, 一貴 organization: 川口市立医療センター循環器内科 – sequence: 1 fullname: 園田, 和正 organization: 東京臨海病院循環器内科 – sequence: 1 fullname: 渡辺, 一郎 organization: 日本大学医学部内科学系循環器内科学分野 – sequence: 1 fullname: 古川, 力丈 organization: 日本大学医学部内科学系循環器内科学分野 – sequence: 1 fullname: 若松, 雄二 organization: 日本大学医学部内科学系循環器内科学分野 – sequence: 1 fullname: 大久保, 公恵 organization: 日本大学医学部内科学系循環器内科学分野 – sequence: 1 fullname: 黒川, 早矢香 organization: 日本大学医学部内科学系循環器内科学分野 – sequence: 1 fullname: 永嶋, 孝一 organization: 日本大学医学部内科学系循環器内科学分野 – sequence: 1 fullname: 渡邉, 隆太 organization: 日本大学医学部内科学系循環器内科学分野 – sequence: 1 fullname: 平山, 篤志 organization: 日本大学医学部内科学系循環器内科学分野 – sequence: 1 fullname: 奥村, 恭男 organization: 日本大学医学部内科学系循環器内科学分野 – sequence: 1 fullname: 高橋, 啓子 organization: 日本大学医学部内科学系循環器内科学分野 – sequence: 1 fullname: 新井, 将 organization: 日本大学医学部内科学系循環器内科学分野 – sequence: 1 fullname: 中井, 俊子 organization: 日本大学医学部内科学系循環器内科学分野 – sequence: 1 fullname: 國本, 聡 organization: 川口市立医療センター循環器内科 – sequence: 1 fullname: 戸坂, 俊雅 organization: 東京臨海病院循環器内科 |
BookMark | eNo9kD9Lw0AAxQ-pYK0d3f0CqZf7k8stghT_QcGls8ddetGWWiWpg2MS0EIWFy0uCqJ0qKKg4qL2w5yxfgwbFZf34P3g8XizoNDZ62gA5m1YIcghi52DXVlhrEIEonQKFG3XJRZkjBdAEULELUgQmQHlMGwqSF3CMSOkCLa-4pvsepBdpNkoGd-l4_6xiYbZSe_j7dlEfRNdTvLP3mj89JClpzm6fzfRuYnTBRMPTXJkktcfHZr4yiRnJrnNk_jFJAOTPM6BaV-2Q13-8xKor67Uq-tWbXNto7pcs1oIcW4pqhtEKSVtTBWaDHM01Ixqz2UUY59JKJmviEMdn9iQQ9tRymtg6kMHKpvjElj6rW2FXbmtxX7Q3JXBoZBBt-m1tcjPEYwJksvkn3_g7chAtCT-BhfFgXQ |
ContentType | Journal Article |
DOI | 10.4264/numa.77.4_255 |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1884-0779 |
EndPage | 260 |
ExternalDocumentID | article_numa_77_4_77_255_article_char_ja |
GroupedDBID | 5GY ALMA_UNASSIGNED_HOLDINGS F5P JSF RJT |
ID | FETCH-LOGICAL-j2299-b5ed4bbba135b27446e0e75ec87533f7a0a7fb4656f4109016bbcd35f060b193 |
ISSN | 0029-0424 |
IngestDate | Wed Sep 03 06:22:42 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | Japanese |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-j2299-b5ed4bbba135b27446e0e75ec87533f7a0a7fb4656f4109016bbcd35f060b193 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/numa/77/4/77_255/_article/-char/ja |
PageCount | 6 |
ParticipantIDs | jstage_primary_article_numa_77_4_77_255_article_char_ja |
PublicationCentury | 2000 |
PublicationDate | 2018/08/01 |
PublicationDateYYYYMMDD | 2018-08-01 |
PublicationDate_xml | – month: 08 year: 2018 text: 2018/08/01 day: 01 |
PublicationDecade | 2010 |
PublicationTitle | 日大医学雑誌 |
PublicationTitleAlternate | 日大医誌 |
PublicationYear | 2018 |
Publisher | 日本大学医学会 |
Publisher_xml | – name: 日本大学医学会 |
References | Zhao DS, Shen Y, Zhang Q, et al. Outcome of catheter ablationof atrial fibrillation in patients with hypertrophic cardiomyopathy;a systemic review and meta-analysis. Europace2016; 18: 508–520. Hayashi H, Hayashi M, Miyauchi Y, et al. Left atrial wallthickness and outcomes of catheter ablation for atrial fibrillationin patients with hypertrophic cardiomyopathy. J IntervCard Electrophysiol 2014; 40: 153–160. Jadidi AS, Cochet H, Shah AJ, et al. Inverse relationship betweenfractionated electrograms and atrial fibrosis in persistentatrial fibrillation. J Am Coll Cardiol 2013; 62: 802–812. Maron BJ. Hypertrophic Cardiomyopathy. Lancet 1997; 350:127–133. Macle L, Khairy P, Weerasooriya R, et al. Adenosine-guidedpulmonary vein isolation for the treatment of paroxysmal atrialfibrillation: an international, multicenter randomized superioritytrial. Lancet 2015; 386: 672–679. Santangeli P, Di Biase L, Themistoclakis S, et al. Catheterablation of atrial fibrillation in hypertrophic cardiomyopathy.Long-term outcomes and mechanism of arrhythmia recurrence.Circulation Arrhythm and Electrophysiol 2013; 6:1089–1094. Sasaki N, Okumura Y, Watanabe I, et al. Frequency analysis ofatrial fibrillation from the specific ECG leads V7-V9: A lowerDF in V9 is a marker of potential atrial remodeling. J of Cardiol2015; 66: 388–394. Ouyang F, Bänsch D, Ernst S, et al. Complete isolation of leftatrium surrounding the pulmonary veins. New insights fromthe double-lasso technique in paroxysmal atrial fibrillation.Circulation 2004; 110: 2090–2096 Manolis AG, Katsivas AG, Lazaris EE, et al. Ventricular performanceand quality of life in patients who underwent radiofrequencyAV junctional ablation and permanent pacemakerimplantation due to medically refractory atrial tachyarrhythmias.J Interv Card Electrophysiol 1998; 2: 71–76 Olivotto I, Cecchi F, Casey SA, et al. Impact of atrial fibrillationon the clinical course of hypertrophic cardiomyopathy.Circulation 2001; 104: 2517–2524 Liu X, Ouyang F, Marvrakis H, et al. Complete pulmonaryvein isolation guided by three-dimensional electroanatomicalmapping for the treatment of paroxysmal atrial fibrillation inpatients with hypertrophic obstructive cardiomyopathy. Europace2005; 7: 421–427. Ha HSK, Wang N, Wong S, et al. Catheter ablation for atrialfibrillation in hypertrophic cardiomyopathy patients: a systemicreview. J Interv Card Electrophysiol 2015; 44: 161–170. Spirito P, Seidman CE, McKenna WJ, et al. The managementof hypertrophic cardiomyopathy. New Engle J Med 1997; 336:775–785. Yoshida K, Rabbani AB, Oral H, et al. Left atrial volume anddominant frequency of atrial fibrillation in patients undergoingcatheter ablation of persistent atrial fibrillation. J Interv CardiovascElectrophysiol 2011; 32:155–161. Gaita F, Di Donna P, Olivotto I, et al. Usefulness and safetyof transcatheter ablation of atrial fibrillation in patients withhypertrophic cardiomyopathy. Am J Cardiol 2007; 99: 1575–1582 Di Donna P, Olivotto I, Delcre SDL, et al. Efficacy of catheterablation of atrial fibrillation in hypertrophic cardiomyopathy:Impact of age, atrial remodeling, and disease progression. Europace2010; 12: 347–355. Nakahara S, Hori Y, Kobayashi S, et al. Epicardial adipose tissue-baseddefragmentation approach to persistent atrial fibrillation:its impact on complex fractionated electrogram and theablation outcome. Heart Rhythm 2014; 11: 1343–1351. Glancy DL, O’Brien KP, Gold HK, et al. Atrial fibrillation inpatients with idiopathic hypertrophic subaortic stenosis. BrHeart J 1970; 32: 652–659. Contrreras-Valdes F, Buxton A, Josephson M, et al. Atrialfibrillation ablation in patients with hypertrophic cardiomyopathy.J Am Coll Cardiol 2015; 65: 1485–1487. Nair GM, Nery PB, Diwakaramenon S, et al. A systematic reviewof randomized trials comparing radiofrequency ablationwith antiarrhythmic medications in patients with atrial fibrillation.J Cardiovasc Electrophysiol. Bunch TJ, Munger TM, Friedman PA, et al. Substrate and proceduralpredictors of outcomes after catheter ablation for atrialfibrillation in patients with hypertrophic cardiomyopathy. JCardiovasc Electrophysiol 200; 19: 1009–1014. Robinson K, Fenneaux MP, Stochins B, et al. Atrial fibrillationin hypertrophic cardiomyopathy: A longitudinal study. J AmColl Cardiol 1990; 15: 1279–1285. Nagashima K, Watanabe I, Okumura Y, et al. High-voltagezones within the pulmonary vein antra: Major determinantsof acute pulmonary vein reconnections after atrial fibrillationablation. J Interv Card Electrophysiol 2017; 49: 137–145. Wilber D, Pappone C, Neuzil P, et al. Comparison of antiarrhythmicdrug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomizedcontrolled trial. JAMA 2010; 303: 333–340 Nademanee K, McKenzie J, Kosar E, et al. A new approachfor catheter ablation: mapping of the electrophysiologic substrate.J Am Coll Cardiol 2004; 43: 2044–2053 Providencia R, Elliott P, Patel K, et al. Catheter ablation foratrial fibrillation in hypertrophic cardiomyopathy: a systemicreview and meta-analysis. Heart 2016; 102: 1533–1543. Kilicaslan F, Verma A, Saad E, et al. Efficacy of catheter ablationof atrial fibrillation in patients with hypertrophic obstructivecardiomyopathy. Heart Rhythm 2006; 3: 275–280. |
References_xml | – reference: Nademanee K, McKenzie J, Kosar E, et al. A new approachfor catheter ablation: mapping of the electrophysiologic substrate.J Am Coll Cardiol 2004; 43: 2044–2053 – reference: Robinson K, Fenneaux MP, Stochins B, et al. Atrial fibrillationin hypertrophic cardiomyopathy: A longitudinal study. J AmColl Cardiol 1990; 15: 1279–1285. – reference: Liu X, Ouyang F, Marvrakis H, et al. Complete pulmonaryvein isolation guided by three-dimensional electroanatomicalmapping for the treatment of paroxysmal atrial fibrillation inpatients with hypertrophic obstructive cardiomyopathy. Europace2005; 7: 421–427. – reference: Nair GM, Nery PB, Diwakaramenon S, et al. A systematic reviewof randomized trials comparing radiofrequency ablationwith antiarrhythmic medications in patients with atrial fibrillation.J Cardiovasc Electrophysiol. – reference: Di Donna P, Olivotto I, Delcre SDL, et al. Efficacy of catheterablation of atrial fibrillation in hypertrophic cardiomyopathy:Impact of age, atrial remodeling, and disease progression. Europace2010; 12: 347–355. – reference: Gaita F, Di Donna P, Olivotto I, et al. Usefulness and safetyof transcatheter ablation of atrial fibrillation in patients withhypertrophic cardiomyopathy. Am J Cardiol 2007; 99: 1575–1582 – reference: Ouyang F, Bänsch D, Ernst S, et al. Complete isolation of leftatrium surrounding the pulmonary veins. New insights fromthe double-lasso technique in paroxysmal atrial fibrillation.Circulation 2004; 110: 2090–2096 – reference: Hayashi H, Hayashi M, Miyauchi Y, et al. Left atrial wallthickness and outcomes of catheter ablation for atrial fibrillationin patients with hypertrophic cardiomyopathy. J IntervCard Electrophysiol 2014; 40: 153–160. – reference: Wilber D, Pappone C, Neuzil P, et al. Comparison of antiarrhythmicdrug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomizedcontrolled trial. JAMA 2010; 303: 333–340 – reference: Glancy DL, O’Brien KP, Gold HK, et al. Atrial fibrillation inpatients with idiopathic hypertrophic subaortic stenosis. BrHeart J 1970; 32: 652–659. – reference: Ha HSK, Wang N, Wong S, et al. Catheter ablation for atrialfibrillation in hypertrophic cardiomyopathy patients: a systemicreview. J Interv Card Electrophysiol 2015; 44: 161–170. – reference: Providencia R, Elliott P, Patel K, et al. Catheter ablation foratrial fibrillation in hypertrophic cardiomyopathy: a systemicreview and meta-analysis. Heart 2016; 102: 1533–1543. – reference: Maron BJ. Hypertrophic Cardiomyopathy. Lancet 1997; 350:127–133. – reference: Bunch TJ, Munger TM, Friedman PA, et al. Substrate and proceduralpredictors of outcomes after catheter ablation for atrialfibrillation in patients with hypertrophic cardiomyopathy. JCardiovasc Electrophysiol 200; 19: 1009–1014. – reference: Kilicaslan F, Verma A, Saad E, et al. Efficacy of catheter ablationof atrial fibrillation in patients with hypertrophic obstructivecardiomyopathy. Heart Rhythm 2006; 3: 275–280. – reference: Santangeli P, Di Biase L, Themistoclakis S, et al. Catheterablation of atrial fibrillation in hypertrophic cardiomyopathy.Long-term outcomes and mechanism of arrhythmia recurrence.Circulation Arrhythm and Electrophysiol 2013; 6:1089–1094. – reference: Nakahara S, Hori Y, Kobayashi S, et al. Epicardial adipose tissue-baseddefragmentation approach to persistent atrial fibrillation:its impact on complex fractionated electrogram and theablation outcome. Heart Rhythm 2014; 11: 1343–1351. – reference: Contrreras-Valdes F, Buxton A, Josephson M, et al. Atrialfibrillation ablation in patients with hypertrophic cardiomyopathy.J Am Coll Cardiol 2015; 65: 1485–1487. – reference: Manolis AG, Katsivas AG, Lazaris EE, et al. Ventricular performanceand quality of life in patients who underwent radiofrequencyAV junctional ablation and permanent pacemakerimplantation due to medically refractory atrial tachyarrhythmias.J Interv Card Electrophysiol 1998; 2: 71–76 – reference: Yoshida K, Rabbani AB, Oral H, et al. Left atrial volume anddominant frequency of atrial fibrillation in patients undergoingcatheter ablation of persistent atrial fibrillation. J Interv CardiovascElectrophysiol 2011; 32:155–161. – reference: Nagashima K, Watanabe I, Okumura Y, et al. High-voltagezones within the pulmonary vein antra: Major determinantsof acute pulmonary vein reconnections after atrial fibrillationablation. J Interv Card Electrophysiol 2017; 49: 137–145. – reference: Olivotto I, Cecchi F, Casey SA, et al. Impact of atrial fibrillationon the clinical course of hypertrophic cardiomyopathy.Circulation 2001; 104: 2517–2524 – reference: Jadidi AS, Cochet H, Shah AJ, et al. Inverse relationship betweenfractionated electrograms and atrial fibrosis in persistentatrial fibrillation. J Am Coll Cardiol 2013; 62: 802–812. – reference: Sasaki N, Okumura Y, Watanabe I, et al. Frequency analysis ofatrial fibrillation from the specific ECG leads V7-V9: A lowerDF in V9 is a marker of potential atrial remodeling. J of Cardiol2015; 66: 388–394. – reference: Zhao DS, Shen Y, Zhang Q, et al. Outcome of catheter ablationof atrial fibrillation in patients with hypertrophic cardiomyopathy;a systemic review and meta-analysis. Europace2016; 18: 508–520. – reference: Macle L, Khairy P, Weerasooriya R, et al. Adenosine-guidedpulmonary vein isolation for the treatment of paroxysmal atrialfibrillation: an international, multicenter randomized superioritytrial. Lancet 2015; 386: 672–679. – reference: Spirito P, Seidman CE, McKenna WJ, et al. The managementof hypertrophic cardiomyopathy. New Engle J Med 1997; 336:775–785. |
SSID | ssib058493744 ssib004298531 ssib001535899 ssib007484389 ssj0000389138 ssib004001855 |
Score | 2.125578 |
SourceID | jstage |
SourceType | Publisher |
StartPage | 255 |
SubjectTerms | アブレーション 心房細動 肥大型心筋症 |
Title | 肥大型心筋症に合併した心房細動に対する カテーテルアブレーション |
URI | https://www.jstage.jst.go.jp/article/numa/77/4/77_255/_article/-char/ja |
Volume | 77 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | 日大医学雑誌, 2018/08/01, Vol.77(4), pp.255-260 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Ni9QwFC_rCuJF_MRv9mBOMmOnbZrkmM50WJQVhBH2ZGk7LTiwq8juxdtMQRfm4kUXLwqi7GEVBRUv6v4xdRz_CA--l6YzndHDupcQkpeX5PeS5qV5eTGMK3GMhz9xXIPhlMIGhdKaiBuNWkpdAZ-GVFDlJGnlprt827m-SlcXDv2uWC1tbkT1-OE_75UcRKqQBnLFW7L_IdkJU0iAOMgXQpAwhPuSMfE54RaRlPiUSIdIhhHhE-5hxGsTbhOfEdlSKYwIRmDz79ugPxKpaIRJOCe-Q7wW8ajOEiWNaFf4uEgJceDjAb2JWcBW0BmGsk08vywuVMQCsqs6hkQ2suOujnjN-RRNA8SWThGTrOZsKYt4rMwqI55d1bix3dCfOYx4k3hFc1tEAnNBBPSkgYBKCbnlOFTo2dgpGIoKJo62IUDmQdXOlAyQbBJhKZAVOIqeYhLUBW3AiuwpvYucpKoQ4PLkHH-hAPGr_Hkbm4_igCpaJX8useW6IK_-w2nwiQVhMesqSLjYWsSyAolG4m9sHARbyOr6ZuFRV3ErvZ4USxrnDszE4smecs3TT-fcrf7QKRawwmmy1oWs4q2H-WUWtWh027u5FtYZqzvBpNSM53I9L_BtmzBgLHAwANKgzMCLhUEPdjeHLcaUkcWNW9UzXJtWz6QdfECSVjf_AnTN6eqEXnHt6dsJoFmD6q2VV6WXqSN5Xtp8IUyF013szrWZzoA62oPNWWnYqXTNznHjmN4kLsmiAyeMhV540jiyos1gThl3fg3ejF7vjF4MR3vZ-N1wvP047--Onmz9-PY572_n_ZeQ_nNrb_zpw2j4FLPef8_7z_PBcCkf7ObZozz7qsLdfPAqz57l2VtMGXzJs508-3ja6LT9TnO5ph9KqfUsUCdrEU26ThRFYcOmEbr8dBMzYTSJ8WeEnbLQDFkaoWfE1EFD7IYbRXHXpqnpmhHs4M4Yi-v31pOzxhIFSFnXCbsJj5w4pMJMbdvsCpeH3ZAn5jmDFcAE9wtnOMF-hXz-wCUvGEenc-aisbjxYDO5BDuBjeiyGjB_AABH2wc |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%82%A5%E5%A4%A7%E5%9E%8B%E5%BF%83%E7%AD%8B%E7%97%87%E3%81%AB%E5%90%88%E4%BD%B5%E3%81%97%E3%81%9F%E5%BF%83%E6%88%BF%E7%B4%B0%E5%8B%95%E3%81%AB%E5%AF%BE%E3%81%99%E3%82%8B+%E3%82%AB%E3%83%86%E3%83%BC%E3%83%86%E3%83%AB%E3%82%A2%E3%83%96%E3%83%AC%E3%83%BC%E3%82%B7%E3%83%A7%E3%83%B3&rft.jtitle=%E6%97%A5%E5%A4%A7%E5%8C%BB%E5%AD%A6%E9%9B%91%E8%AA%8C&rft.au=%E7%A3%AF%2C+%E4%B8%80%E8%B2%B4&rft.au=%E5%9C%92%E7%94%B0%2C+%E5%92%8C%E6%AD%A3&rft.au=%E6%B8%A1%E8%BE%BA%2C+%E4%B8%80%E9%83%8E&rft.au=%E5%8F%A4%E5%B7%9D%2C+%E5%8A%9B%E4%B8%88&rft.date=2018-08-01&rft.pub=%E6%97%A5%E6%9C%AC%E5%A4%A7%E5%AD%A6%E5%8C%BB%E5%AD%A6%E4%BC%9A&rft.issn=0029-0424&rft.eissn=1884-0779&rft.volume=77&rft.issue=4&rft.spage=255&rft.epage=260&rft_id=info:doi/10.4264%2Fnuma.77.4_255&rft.externalDocID=article_numa_77_4_77_255_article_char_ja |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0029-0424&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0029-0424&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0029-0424&client=summon |